On CNBC's “Halftime Report Final Trades,” Stephen L. Weiss of Short Hills Capital Partners recommended buying TransDigm Group Incorporated TDG.
On Aug. 6, TransDigm Group reported better-than-expected third-quarter financial results and raised its FY24 guidance above estimates.
Jason Snipe of Odyssey Capital Advisors said BJ’s Wholesale Club Holdings, Inc. BJ beat on the bottom line.
On Aug. 22, BJ’s Wholesale reported better-than-expected second-quarter financial results. Revenue growth of 4.9% Y/Y to $5.205 billion, beating the analyst consensus estimate of $5.145 billion. Total comparable club sales increased by 3.1%. Comparable club sales, excluding gasoline sales, increased by 2.4%.
Don't forget to check out our premarket coverage here
Anastasia Amoroso of iCapital picked VanEck Semiconductor ETF SMH, saying semiconductor space is down 17%, so it's a good place to add.
Joe Terranova of Virtus Investment Partners named AbbVie Inc. ABBV as his final trade.
On Sept. 10, AbbVie’s CONSTELLA received Health Canada approval for treating childhood constipation. “Constipation is a common issue in childhood that can significantly impact a child’s quality of life and cause considerable stress for their families. These children and families will be grateful to have a new prescription treatment option that can offer symptom relief and improve the overall well-being of the child and family, making daily life more manageable,” said Dr. Melanie Schmidt, Division of Paediatric Gastroenterology and Hepatology at Children’s Hospital in London, Ontario.
Price Action:
- TransDigm gained 0.4% to close at $1,372.92 during Monday's session.
- BJ’s Wholesale shares fell 1.1% to settle at $80.57 on Monday.
- VanEck Semiconductor ETF fell 1.3% during Monday's session.
- AbbVie shares gained 0.8% to settle at $195.73 during Monday's session.
Check This Out:
Image generated using artificial intelligence via Midjourney.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.